ZYUS Life Sciences Insiders Placed Bullish Bets Worth CA$847.3k

In This Article:

It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it happened in ZYUS Life Sciences Corporation's (CVE:ZYUS) case, it's fantastic news for shareholders.

While insider transactions are not the most important thing when it comes to long-term investing, we would consider it foolish to ignore insider transactions altogether.

Check out our latest analysis for ZYUS Life Sciences

ZYUS Life Sciences Insider Transactions Over The Last Year

Notably, that recent purchase by Wayne Brownlee is the biggest insider purchase of ZYUS Life Sciences shares that we've seen in the last year. That means that even when the share price was higher than CA$0.90 (the recent price), an insider wanted to purchase shares. While their view may have changed since the purchase was made, this does at least suggest they have had confidence in the company's future. We always take careful note of the price insiders pay when purchasing shares. Generally speaking, it catches our eye when insiders have purchased shares at above current prices, as it suggests they believed the shares were worth buying, even at a higher price.

Over the last year, we can see that insiders have bought 897.36k shares worth CA$847k. But insiders sold 654.00k shares worth CA$602k. In total, ZYUS Life Sciences insiders bought more than they sold over the last year. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

insider-trading-volume
insider-trading-volume

There are plenty of other companies that have insiders buying up shares. You probably do not want to miss this free list of undervalued small cap companies that insiders are buying.

ZYUS Life Sciences Insiders Bought Stock Recently

Over the last three months, we've seen significantly more insider buying, than insider selling, at ZYUS Life Sciences. Insiders spent CA$650k on shares. On the other hand, President Brent Zettl netted CA$432k by selling. We think insiders may be optimistic about the future, since insiders have been net buyers of shares.

Does ZYUS Life Sciences Boast High Insider Ownership?

I like to look at how many shares insiders own in a company, to help inform my view of how aligned they are with insiders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. ZYUS Life Sciences insiders own about CA$34m worth of shares (which is 51% of the company). I like to see this level of insider ownership, because it increases the chances that management are thinking about the best interests of shareholders.